Search all medical codes

Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg

HCPCS code

Name of the Procedure:

Common Name: Andexxa Injection
Technical/Medical Term: Injection, coagulation factor Xa (recombinant), inactivated-zhzo (J7169)

Summary

Andexxa is an injection given to counteract the effects of certain anticoagulant medications that inhibit Factor Xa. It's often used in emergency situations to reverse life-threatening or uncontrolled bleeding.

Purpose

Medical Conditions:
  • Emergency reversal of anticoagulation in patients treated with Factor Xa inhibitors. ##### Goals:
  • Stop active bleeding
  • Prevent further bleeding complications
  • Stabilize the patient's condition

Indications

  • Major bleeding episodes
  • Urgent need for surgery or invasive procedures in patients on Factor Xa inhibitors
  • Evidence of severe overdose with Factor Xa inhibitors

Preparation

Pre-Procedure Instructions:
  • Inform the healthcare team about all medications and supplements you are taking.
  • You may need to fast for a certain period before the procedure. ##### Diagnostic Tests:
  • Blood tests to measure coagulation status and effectiveness of anticoagulation therapy.

Procedure Description

  1. Preparation: Establish an IV line and prepare the appropriate dose of Andexxa based on the patient's coagulation status and body weight.
  2. Injection: Administer Andexxa through the IV line over a recommended time period.
  3. Monitoring: Continuous monitoring of vital signs and coagulation parameters during and after the administration.
  4. Post-Injection Care: Observe for any signs of adverse reactions or complications.
Tools/Equipment
  • IV line
  • Syringes for the Andexxa injection
  • Monitoring devices for vital signs and coagulation status
Anesthesia or Sedation
  • Generally not required for this procedure.

Duration

The injection itself typically takes about 30 minutes to administer, but monitoring may extend for several hours.

Setting

  • Hospital
  • Intensive care unit (ICU)
  • Emergency Department

Personnel

  • Physicians (e.g. hematologists, emergency medicine specialists)
  • Nurses
  • Pharmacists

Risks and Complications

Common Risks:
  • Infusion-related reactions (e.g., headache, dizziness)
  • Nausea
Rare Risks:
  • Blood clots
  • Cardiac events
  • Anaphylaxis
Management:
  • Immediate medical intervention for any severe reactions.
  • Close monitoring and supportive care for less severe side effects.

Benefits

  • Rapid reversal of anticoagulation
  • Reduction of bleeding complications
  • Ability to undergo urgent surgical procedures safely

Recovery

Post-Procedure Care:
  • Continuous monitoring for any adverse effects ##### Recovery Time:
  • Varies based on the extent of the bleeding and the patient's overall condition
  • Patients may need ongoing monitoring and follow-up appointments

Alternatives

Other Treatment Options:
  • Use of blood products (e.g., plasma)
  • Protamine sulfate (for heparin reversal, not specific to Factor Xa inhibitors)
Pros and Cons:
  • Blood products may not be as quick or specific in reversal.
  • Protamine sulfate is not effective against Factor Xa inhibitor-induced anticoagulation.

Patient Experience

  • During the procedure, you might feel a slight prick from the IV insertion.
  • Post-procedure monitoring ensures you are safe and stable.
  • Minimal discomfort is expected, though you may feel fatigued or have mild side effects such as nausea.
  • Pain management and comfort measures will be provided as needed.

Similar Codes